Yayın:
Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?

Basit Görünüm
dc.contributor.authorİnanç, Nevsun
dc.contributor.authorÖzen, Gülşen
dc.contributor.authorYalçınkaya, Yasemin
dc.contributor.authorKoca, Süleyman Serdar
dc.contributor.authorCan, Gerçek
dc.contributor.authorKarataş, Ahmet
dc.contributor.authorYazıcı, Ayten
dc.contributor.authorCefle, Ayşe
dc.contributor.authorTufan, Abdurrahman
dc.contributor.authorAkar, Servet
dc.contributor.authorŞenel, Soner
dc.contributor.authorÖz, Burak
dc.contributor.authorAkkoç, Nurullah
dc.contributor.authorÖnen, Fatoş
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.buuauthorPehlivan, Yavuz
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentRomatoloji Bilim Dalı
dc.contributor.researcheridCMF-4757-2022
dc.contributor.researcheridFQP-0451-2022
dc.date.accessioned2024-01-10T12:23:14Z
dc.date.available2024-01-10T12:23:14Z
dc.date.issued2018-06
dc.descriptionBu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean League Against Rheumatism
dc.identifier.citationİnanç, N. vd. (2018). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Annals of the Rheumatic Diseases, 77(Supplement 2), 611-612.
dc.identifier.doi10.1136/annrheumdis-2018-eular.5662
dc.identifier.eissn1468-2060
dc.identifier.endpage612
dc.identifier.issn0003-4967
dc.identifier.issueSupplement 2
dc.identifier.startpage611
dc.identifier.urihttps://ard.bmj.com/content/77/Suppl_2/611.2
dc.identifier.urihttps://hdl.handle.net/11452/38944
dc.identifier.volume77
dc.identifier.wos000444351001597
dc.indexed.wosSCIE
dc.indexed.wosCPCIS
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.collaborationYurt içi
dc.relation.journalAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatology
dc.subject.wosRheumatology
dc.titleIs there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?
dc.typeArticle
dc.wos.quartileQ1 (Rheumatology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Romatoloji Bilim Dalı
local.indexed.atPubMed

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Küçük Resim
Ad:
Dalkılıç_vd_2018.pdf
Boyut:
577.59 KB
Format:
Adobe Portable Document Format
Açıklama
İndir

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications